{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:39:55Z","timestamp":1770457195363,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vph.2019.106608","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T03:33:23Z","timestamp":1572752003000},"page":"106608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban"],"prefix":"10.1016","volume":"124","author":[{"given":"Tatiane","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephany Cares","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"de Moraes Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlindo Lemos","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Husemann","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Andrade","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Fernando","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Frederico Gerbase","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Ragazzi","family":"Sodre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayana Teixeira","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauber","family":"Rielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Pereira","family":"Colella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich Vinicius","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela G.","family":"Yamaguti-Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silmara","family":"Montalv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce M.","family":"Annichino-Bizzacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vph.2019.106608_bb0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1538-7836.2006.01824.x","article-title":"Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux [9]","volume":"4","author":"Kahn","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106608_bb0010","first-page":"1","article-title":"Additional catheter-directed thrombolysis for high proximal deep vein thrombosis; 5 year results of a randomized controlled trial (the CaVenT study)","volume":"13","author":"Haig","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"9920","key":"10.1016\/j.vph.2019.106608_bb0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet."},{"issue":"9810","key":"10.1016\/j.vph.2019.106608_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.vph.2019.106608_bb0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2012.04872.x","article-title":"Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study","volume":"10","author":"Chitsike","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.vph.2019.106608_bb0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.vph.2019.106608_bb0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jvs.2008.01.008","article-title":"Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial","volume":"47","author":"Aschwanden","year":"2008","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.vph.2019.106608_bb0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jvs.2008.05.033","article-title":"Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin","volume":"48","author":"Gonz\u00e1lez-Fajardo","year":"2008","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.vph.2019.106608_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1538-7836.2009.03286.x","article-title":"Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study","volume":"7","author":"Roumen-Klappe","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.vph.2019.106608_bb0050","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","article-title":"Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization","volume":"7","author":"Kahn","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106608_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2017.10.022","article-title":"Diagnostic scales for the post-thrombotic syndrome","volume":"164","author":"Wik","year":"2018","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.vph.2019.106608_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1544161","article-title":"The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation","volume":"41","author":"Prandoni","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"18","key":"10.1016\/j.vph.2019.106608_bb0065","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American heart association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.vph.2019.106608_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1538-7836.2005.01333.x","article-title":"Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome","volume":"3","author":"Van Dongen","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.vph.2019.106608_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1076029618758955","article-title":"Postthrombotic syndrome in patients treated with rivaroxaban or warfarin for venous thromboembolism","volume":"24","author":"Coleman","year":"2018","journal-title":"Clin. Appl. Thromb."},{"issue":"10","key":"10.1016\/j.vph.2019.106608_bb0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1160\/TH16-01-0041","article-title":"Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis","volume":"116","author":"Cheung","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106608_bb0085","doi-asserted-by":"crossref","unstructured":"Jeraj L, Jezovnik MK, Poredos P. Insuf fi cient recanalization of thrombotic venous occlusion \u2014 risk for Postthrombotic syndrome. J. Vasc. Interv. Radiol. (8). Available from: doi:https:\/\/doi.org\/10.1016\/j.jvir.2017.03.031.","DOI":"10.1016\/j.jvir.2017.03.031"},{"key":"10.1016\/j.vph.2019.106608_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.thromres.2018.01.013","article-title":"Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome","volume":"163","author":"Utne","year":"2018","journal-title":"Thromb Res [Internet]."},{"issue":"20 SUPPL","key":"10.1016\/j.vph.2019.106608_bb0095","article-title":"Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome","volume":"63","author":"MacDougall","year":"2006","journal-title":"Am J Heal Pharm."},{"key":"10.1016\/j.vph.2019.106608_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11239-009-0309-3","article-title":"Incidence and cost burden of post-thrombotic syndrome","volume":"28","author":"Ashrani","year":"2009","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.vph.2019.106608_bb0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.thromres.2005.12.005","article-title":"A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil","volume":"118","author":"Ramacciotti","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2019.106608_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1160\/TH07-11-0678","article-title":"Inter-observer reliability of measures to assess the post-thrombotic syndrome","volume":"100","author":"Rodger","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.vph.2019.106608_bb0115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1538-7836.2008.03002.x","article-title":"Determinants of health-related quality of life during the 2 years following deep vein thrombosis","volume":"6","author":"Kahn","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2019.106608_bb0120","article-title":"Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis [Internet]","volume":"132","author":"ten Cate-Hoek","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.vph.2019.106608_bb0125","doi-asserted-by":"crossref","first-page":"e0164076","DOI":"10.1371\/journal.pone.0164076","article-title":"Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry","volume":"11","author":"Haas","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2019.106608_bb0130","first-page":"1","article-title":"Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?","volume":"37","author":"Ramacciotti","year":"2018","journal-title":"International Angiology. Edizioni Minerva Medica"},{"issue":"3","key":"10.1016\/j.vph.2019.106608_bb0135","first-page":"82","article-title":"Recanalization of lower-limb deep veins as an index of efficacy of treatment for acute venous thrombosis","volume":"22","author":"Kuznetsov","year":"2016","journal-title":"Angiol. Sosud. Khir."},{"key":"10.1016\/j.vph.2019.106608_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2017.03.022","article-title":"Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants","volume":"153","author":"Prandoni","year":"2017","journal-title":"Thromb. Res."}],"updated-by":[{"DOI":"10.1016\/j.vph.2020.106780","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119302149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119302149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:18:49Z","timestamp":1761527929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189119302149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":28,"alternative-id":["S1537189119302149"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2019.106608","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2019.106608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106608"}}